Enhanced XPA mRNA levels in cisplatin-resistant human ovarian cancer are not associated with XPA mutations or gene amplification. [electronic resource]
Producer: 19970109Description: 233-7 p. digitalISSN:- 0304-3835
- Antineoplastic Agents -- pharmacology
- Cisplatin -- pharmacology
- DNA-Binding Proteins -- genetics
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Amplification
- Humans
- Mutation -- genetics
- Neoplasm Proteins -- genetics
- Ovarian Neoplasms -- genetics
- Polymorphism, Single-Stranded Conformational
- RNA, Messenger -- genetics
- Tumor Suppressor Protein p53 -- metabolism
- Xeroderma Pigmentosum Group A Protein
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.